Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis.

@article{Eaton2003MyocardialCP,
  title={Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis.},
  author={Simon Eaton and Koji Fukumoto and Giorgio Stefanutti and Lewis Spitz and Victor A. Zammit and Agostino Pierro},
  journal={Biochemical Society transactions},
  year={2003},
  volume={31 Pt 6},
  pages={
          1133-6
        }
}
CPT I (outer membrane carnitine palmitoyltransferase I) is a crucial enzyme in myocardial substrate selection. Two isoforms exist in the heart, the liver (L-) and muscle (M-) isoforms, which have different kinetic characteristics and alter in relative amounts during the neonatal/weaning/adult transition. CPT I is a point for control and regulation of fatty acid oxidation via modulation of its activity by malonyl-CoA, the concentration of which is set by acetyl-CoA carboxylase, AMP-activated… 

Figures from this paper

Carnitine palmitoyltransferase 1: Central to cell function
  • V. Zammit
  • Biology, Computer Science
    IUBMB life
  • 2008
TLDR
The inhibition of CPT 1 by malonyl-CoA is crucial because it is the point at which metabolism of fatty acids and glucose come into the most direct ‘‘contact’’ to influence each other’s metabolism.
Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy?
TLDR
Research on CPT activation or inhibition highlights the pharmacological modulation of CPT-dependent FAO, especially on different CPT isoforms, as a promising anti-inflammatory/antitumor therapeutic strategy for numerous disorders.
Structural insight into function and regulation of carnitine palmitoyltransferase
TLDR
The CPT-2 crystal structures have advanced understanding of CPT structure–function relationships and will facilitate discovery of novel inhibitors by structure-based drug design, however, a number of unresolved questions regarding the biochemistry and pharmacology of C PT enzymes remain.
A VIEW OF L- CARNITINE IN HEALTH AND DISEASES
TLDR
Current knowledge of carnitine biology in health and disease is presented, including its established function as a carrier of activated fatty acids and activates acetate across the inner mitochondrial membrane.
Nitric oxide signaling gone awry: Nitration of glutamine synthetase and hyperammonemia in sepsis
TLDR
It is proposed that high levels of NO lead to a bioenergetic dysfunction with some of the characteristics of hypoxia, but with enhanced ROS formation and the oxidative modification of mitochondrial proteins; a process the authors have termed NO-dependenthypoxia or nitroxia.
ReviewRole of carnitine in disease
TLDR
The purpose of this review is to summarize the role of carnitine in human nutrition and disease and highlight the major areas of research in this field.
Role of carnitine in disease
TLDR
Clinical application of carnitine holds much promise in a range of neural disorders such as Alzheimer's disease, hepatic encephalopathy and other painful neuropathies and topical application in dry eye offers osmoprotection and modulates immune and inflammatory responses.
Mitochondrial protein tyrosine nitration
TLDR
The biochemical mechanisms of protein tyrosine nitration within mitochondria, the main nitration protein targets and the impact of 3-nitrotyrosine formation in the structure, function and fate of modified mitochondrial proteins are assessed.
Reviewof carnitine in disease
TLDR
Clinical application of carnitine holds much promise in a range of neural disorders such as Alzheimer's disease, hepatic encephalopathy and other painful neuropathies and topical application in dry eye offers osmoprotection and modulates immune and inflammatory responses.
...
1
2
3
...

References

SHOWING 1-2 OF 2 REFERENCES
Pediatric Surgery (O’Neill
  • 1998
Surg., in the press
  • 1994